findmyKOL

Hani Kushlaf, MD

Basic profile

Cincinnati Children's Hospital Medical Center

ORCIDNPI
RegionCincinnati, OH · MidwestSpecialtyNeurologyFocusNeurology
Active KOLfindmyKOL typefindmyKOL type: our influence ranking, shown when you reveal the full profileLatest publication2025Online presenceNot yet checkedPayments2021 onwardNIH fundingNot yet indexedWhy? →

Hani Kushlaf is a Neurology physician affiliated with Cincinnati Children's Hospital Medical Center. OpenAlex indexes 79 publications with 809 citations (h-index 14).

Overview

Scholarship

indexed output and impact (OpenAlex)
View publications ↓
79publications

Distinct works indexed by OpenAlex, matched via ORCID.

809citations

Total citations across indexed works.

14h-index

Hirsch index, productivity × impact (OpenAlex).

Clinical & industry

trials, payments and federal funding
12companies · 2021 onward

Companies reporting payments to CMS. Facts, not judgments.

View payments

Industry payments

12 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:

12 companies with payments on record in CMS Open Payments (2021 onward), matched to this physician's NPI. The itemized breakdown by company, amount and year is part of the full profile. Why? →

Medicare prescribing footprint (2023)

The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.

  • Nervous system

    31.3%
    Gabapentinoids17.1%
    Gabapentin81%Pregabalin19%
    Part D<11 patients
    Cholinesterase Inhibitor14.2%
    Pyridostigmine Bromide100%
    Part D14 patients
  • Metabolism & gastrointestinal

    26%
    Corticosteroid22.1%
    Prednisone100%
    Part D<11 patients
    Hydrolytic Lysosomal Glycogen-specific Enzyme3.8%
    Nexviazyme100%
    Part D<11 patients
  • Cancer & immunology

    25.4%
    Purine Antimetabolite20.4%
    Azathioprine100%
    Part D15 patients
    Folate Analog Metabolic Inhibitor5%
    Methotrexate100%
    Part D<11 patients
Where care is delivered (Part B)100% facility · 0% office

Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.

Publications

Matched to this physician's OpenAlex author record; most-cited works shown first.

Similar KOLs

Other experts from the same institution or the same specialty.

A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”